uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted December 02, 2014

Glucosamine Class-Action Settlement Reversed by Appeals Court

On November 19, 2014, an appeals court rejected a settlement of a class-action lawsuit that alleged label claims on glucosamine products manufactured or sold by Rexall Sundown, Inc., NBTY, Inc. or their affiliates, were false, deceptive or misleading. Although the settlement was preliminarily approved by a U.S. District Court in 2013, the Appeals Court reversed the decision, finding that the agreement did not require a significant change in the wording of label claims, or provide fair compensation to the majority of consumers who have purchased the products.

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at